A Mutation Linked with Autism Reveals a Common Mechanism of Endoplasmic Reticulum Retention for the α,β-Hydrolase Fold Protein Family*

A mutation linked to autistic spectrum disorders encodes an Arg to Cys replacement in the C-terminal portion of the extracellular domain of neuroligin-3. The solvent-exposed Cys causes virtually complete retention of the protein in the endoplasmic reticulum when the protein is expressed in transfected cells. An identical Cys substitution was reported for butyrylcholinesterase through genotyping patients with post-succinylcholine apnea. Neuroligin, butyrylcholinesterase, and acetylcholinesterase are members of the α,β-hydrolase fold family of proteins sharing sequence similarity and common tertiary structures. Although these proteins have distinct oligomeric assemblies and cellular dispositions, homologous Arg residues in neuroligin-3 (Arg-451), in butyrylcholinesterase (Arg-386), and in acetylcholinesterase (Arg-395) are conserved in all studied mammalian species. To examine whether an homologous Arg to Cys mutation affects related proteins similarly despite their differing capacities to oligomerize, we inserted homologous mutations in the acetylcholinesterase and butyrylcholinesterase cDNAs. Using confocal fluorescence microscopy and analysis of oligosaccharide processing, we find that the homologous Arg to Cys mutation also results in endoplasmic reticulum retention of the two cholinesterases. Small quantities of mutated acetylcholinesterase exported from the cell retain activity but show a greater Km, a much smaller kcat, and altered substrate inhibition. The nascent proteins associate with chaperones during processing, but the mutation presumably restricts processing through the endoplasmic reticulum and Golgi apparatus, because of local protein misfolding and inability to oligomerize. The mutation may alter the capacity of these proteins to dissociate from their chaperone prior to oligomerization and processing for export.

[1]  T. Südhof,et al.  Dissection of Synapse Induction by Neuroligins , 2005, Journal of Biological Chemistry.

[2]  J. Sussman,et al.  Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. , 2005, Current opinion in pharmacology.

[3]  R. Souza,et al.  Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample. , 2005, Molecular genetics and metabolism.

[4]  N. Craddock,et al.  Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients , 2005, Molecular Psychiatry.

[5]  C. Lam,et al.  Novel mutations in the BCHE gene in patients with no butyrylcholinesterase activity. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[6]  Ann Marie Craig,et al.  Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins , 2004, Cell.

[7]  P. Scheiffele,et al.  Disorder-associated mutations lead to functional inactivation of neuroligins. , 2004, Human molecular genetics.

[8]  Igor Tsigelny,et al.  The Arg451Cys-Neuroligin-3 Mutation Associated with Autism Reveals a Defect in Protein Processing , 2004, The Journal of Neuroscience.

[9]  I. Tsigelny,et al.  Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. , 2004, Biochemistry.

[10]  S. Jamain,et al.  Neuroligin 2 is exclusively localized to inhibitory synapses. , 2004, European journal of cell biology.

[11]  Davide Comoletti,et al.  Characterization of the Interaction of a Recombinant Soluble Neuroligin-1 with Neurexin-1β* , 2003, Journal of Biological Chemistry.

[12]  P. Scheiffele,et al.  Making connections: cholinesterase-domain proteins in the CNS , 2003, Trends in Neurosciences.

[13]  Yvain Nicolet,et al.  Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products* , 2003, Journal of Biological Chemistry.

[14]  E. Komives,et al.  Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry. , 2003, Biochemistry.

[15]  D. Sullivan,et al.  Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. , 2003, Clinical chemistry.

[16]  E. Isacoff,et al.  Neurexin mediates the assembly of presynaptic terminals , 2003, Nature Neuroscience.

[17]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[18]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[19]  Zoran Radić,et al.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site , 2003, The EMBO journal.

[20]  P. Taylor,et al.  Reversibly Bound and Covalently Attached Ligands Induce Conformational Changes in the Omega Loop, Cys69–Cys96, of Mouse Acetylcholinesterase* , 2001, The Journal of Biological Chemistry.

[21]  T. Südhof,et al.  Common EF‐hand motifs in cholinesterases and neuroligins suggest a role for Ca2+ binding in cell surface associations , 2008, Protein science : a publication of the Protein Society.

[22]  M. Holmquist,et al.  Alpha/Beta-hydrolase fold enzymes: structures, functions and mechanisms. , 2000, Current protein & peptide science.

[23]  P. Taylor,et al.  Probing the Active Center Gorge of Acetylcholinesterase by Fluorophores Linked to Substituted Cysteines* , 2000, The Journal of Biological Chemistry.

[24]  R. Fetter,et al.  Neuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons , 2000, Cell.

[25]  M. Nardini,et al.  α/β Hydrolase fold enzymes : the family keeps growing , 1999 .

[26]  J. Deisenhofer,et al.  Regulation of LNS Domain Function by Alternative Splicing: The Structure of the Ligand-Binding Domain of Neurexin Iβ , 1999, Cell.

[27]  T. Südhof,et al.  Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Legay,et al.  Acetylcholinesterase: C-terminal domains, molecular forms and functional localization , 1998, Journal of Physiology-Paris.

[29]  O. Lockridge,et al.  Tetramerization domain of human butyrylcholinesterase is at the C-terminus. , 1997, The Biochemical journal.

[30]  W. Welch,et al.  Correcting temperature-sensitive protein folding defects. , 1997, The Journal of clinical investigation.

[31]  J L Sussman,et al.  Soluble monomeric acetylcholinesterase from mouse: Expression, purification, and crystallization in complex with fasciculin , 1996, Protein science : a publication of the Protein Society.

[32]  B. Reinhold,et al.  Glycoinositol phospholipid anchor and protein C-terminus of bovine erythrocyte acetylcholinesterase: analysis by mass spectrometry and by protein and DNA sequencing. , 1996, The Biochemical journal.

[33]  T. Südhof,et al.  Structures, Alternative Splicing, and Neurexin Binding of Multiple Neuroligins (*) , 1996, The Journal of Biological Chemistry.

[34]  T. Südhof,et al.  Neuroligin 1: A splice site-specific ligand for β-neurexins , 1995, Cell.

[35]  P Taylor,et al.  Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. , 1993, Biochemistry.

[36]  J. Sussman,et al.  Relationship between sequence conservation and three‐dimensional structure in a large family of esterases, lipases, and related proteins , 1993, Protein science : a publication of the Protein Society.

[37]  P. Taylor,et al.  Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. , 1993, Biochemistry.

[38]  A. Shafferman,et al.  Interrelations between assembly and secretion of recombinant human acetylcholinesterase. , 1993, The Journal of biological chemistry.

[39]  I. Silman,et al.  Chemical modification of Torpedo acetylcholinesterase by disulfides: appearance of a "molten globule" state. , 1992, Biochemistry.

[40]  J. Massoulie,et al.  H and T subunits of acetylcholinesterase from Torpedo, expressed in COS cells, generate all types of globular forms , 1992, The Journal of cell biology.

[41]  A. Shafferman,et al.  The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant. , 1991, The Journal of biological chemistry.

[42]  P. Taylor,et al.  Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression. , 1991, The Journal of biological chemistry.

[43]  C. Alberini,et al.  Developmental regulation of IgM secretion: The role of the carboxy-terminal cysteine , 1990, Cell.

[44]  I. Silman,et al.  Modes of attachment of acetylcholinesterase to the surface membrane. , 1987, European journal of biochemistry.

[45]  O. Lockridge,et al.  Location of disulfide bonds within the sequence of human serum cholinesterase. , 1987, The Journal of biological chemistry.

[46]  Susan S. Taylor,et al.  Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence , 1986, Nature.

[47]  I. Silman,et al.  Physicochemical behaviour and structural characteristics of membrane-bound acetylcholinesterase from Torpedo electric organ. Effect of phosphatidylinositol-specific phospholipase C. , 1985, The Biochemical journal.

[48]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[50]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.